62.33
price up icon9.12%   5.21
 
loading

Novo Nordisk Adr 주식(NVO)의 최신 뉴스

pulisher
Jan 16, 2026

Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer - Finviz

Jan 16, 2026
pulisher
Jan 16, 2026

Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data - Benzinga

Jan 16, 2026
pulisher
Jan 15, 2026

Europe’s ADR Index Was Flat, But Single Stocks Were Not - Finimize

Jan 15, 2026
pulisher
Jan 13, 2026

Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026? - Finviz

Jan 13, 2026
pulisher
Jan 13, 2026

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026? - Finviz

Jan 13, 2026
pulisher
Jan 12, 2026

Looking At Novo Nordisk's Recent Unusual Options Activity - Sahm

Jan 12, 2026
pulisher
Jan 10, 2026

Can Novo Nordisk A s (b Shares) Adrhedged stock continue upward trendWeekly Loss Report & Daily Risk Controlled Trade Plans - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Novo Nordisk gets a fresh $73.50 target as Amazon starts selling the Wegovy pill - TechStock²

Jan 09, 2026
pulisher
Jan 09, 2026

Novo Nordisk A/S (B Shares) ADRhedged (BATS:NVOH) Trading 0.4% Higher – What’s Next? - Defense World

Jan 09, 2026
pulisher
Jan 09, 2026

CICC Initiates Coverage on Novo Nordisk with Outperform Rating and $73.50 Price Target for U.S. ADRBN - marketscreener.com

Jan 09, 2026
pulisher
Jan 06, 2026

European ADRs Rose In US Trading As Chip And Pharma Led - Finimize

Jan 06, 2026
pulisher
Jan 06, 2026

Will Novo Nordisk A s (b Shares) Adrhedged stock benefit from infrastructure spending2026 world cup usa national team semifinals star players high defensive line winner prediction tactical review - Улправда

Jan 06, 2026
pulisher
Jan 05, 2026

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Sahm

Jan 05, 2026
pulisher
Jan 05, 2026

G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.

Jan 05, 2026
pulisher
Jan 03, 2026

2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 - Finviz

Jan 03, 2026
pulisher
Jan 01, 2026

Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill - Finviz

Jan 01, 2026
pulisher
Dec 31, 2025

FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026 - Finviz

Dec 31, 2025
pulisher
Dec 30, 2025

The Truth About Novo Nordisk A/S (ADR): Is Wall Street’s Favorite ‘Skinny Stock’ Still Worth t - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Why Novo Nordisk Stock Dropped on Monday - Finviz

Dec 30, 2025
pulisher
Dec 30, 2025

Where is Novo Nordisk A/S (NVO) Headed? - Finviz

Dec 30, 2025
pulisher
Dec 29, 2025

Novo Nordisk Halves Wegovy Prices In China Ahead Of Generic Threat - Sahm

Dec 29, 2025
pulisher
Dec 29, 2025

Novo Nordisk (NVO) Gets 9% Boost from Wegovy Pill OK - Finviz

Dec 29, 2025
pulisher
Dec 26, 2025

Should You Invest in Ozempic Maker Novo Nordisk in 2026? - Finviz

Dec 26, 2025
pulisher
Dec 24, 2025

The New York Stock Exchange | NYSE - NYSE

Dec 24, 2025
pulisher
Dec 24, 2025

Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus

Dec 24, 2025
pulisher
Dec 23, 2025

Why Novo Nordisk Stock Popped Today - Finviz

Dec 23, 2025
pulisher
Dec 23, 2025

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm

Dec 23, 2025
pulisher
Dec 23, 2025

Novo Nordisk stock split: what’s next for NVO shares? - Capital.com

Dec 23, 2025
drug_manufacturers_general NVS
$144.34
price up icon 0.83%
drug_manufacturers_general MRK
$108.83
price down icon 1.93%
$330.41
price up icon 0.12%
$214.35
price down icon 1.11%
$124.91
price up icon 3.01%
자본화:     |  볼륨(24시간):